News | April 12, 2022
One-dose HPV vaccine offers solid protection against cervical cancer
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
BioFluidica LiquidScan harnesses the power of microfluidics
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
Recommendation is based on pivotal data from the phase III POLARIX study
The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step
Subscribe To Our Newsletter & Stay Updated
